SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-005256
Filing Date
2015-11-23
Accepted
2015-11-23 09:04:14
Documents
4
Period of Report
2015-11-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8k.htm 8-K 33705
2 PRESS RELEASE DATED NOVEMBER 23, 2015. tbuff_ex991.htm EX-99.1 22879
3 pozenlogo.jpg GRAPHIC 9953
4 tbuff_ex99112.jpg GRAPHIC 6401
  Complete submission text file 0001354488-15-005256.txt   80632
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 151248441
SIC: 2834 Pharmaceutical Preparations